title: Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour.
authors.affiliation: Department of Medical Oncology, National Cancer Centre, Singapore.
authors.forename: Han Chong
authors.initials: HC
authors.lastname: Toh
authors.forename: Marissa
authors.initials: M
authors.lastname: Teo
authors.forename: Kong Wee
authors.initials: KW
authors.lastname: Ong
authors.forename: Victor
authors.initials: V
authors.lastname: Lee
authors.forename: Errol
authors.initials: E
authors.lastname: Chan
authors.forename: Ann S G
authors.initials: AS
authors.lastname: Lee
authors.forename: Anantharaman
authors.initials: A
authors.lastname: Vathsala
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000821:virology; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D004854:Herpesvirus 4, Human; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000821:virology; D008875:Middle Aged; D020123:Sirolimus / Q000627:therapeutic use*; D018235:Smooth Muscle Tumor / Q000188:drug therapy* / Q000821:virology
chemical_list: D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D020123:Sirolimus